Navigating Your Acute Heart Failure Patient in Emergency and Pre-Discharge Phase

https://doi.org/10.22146/aci.47680

Budi Yuli Setianto(1*)

(1) Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada – Dr. Sardjito General Hospital, Yogyakarta, Indonesia
(*) Corresponding Author

Abstract


Heart failure (HF) leads to frequent hospitalizations. The presence of re-hospitalization risk among patientshospitalized for heart failure is important, especially hemodynamic instability and neurohormonal over activation. ARNI is needed to restore the balance of neurohormonal system in HF. PARADIGM-HF study provide insight on long term benefit of ARNI (i.e. sacubitril/valsartan) in ambulatory setting. How is the evidence of ARNI use for in hospitalization phase of HF? PIONEER and TRANSITION showed that initiation of sacubitril/valsartan shortly after an ADHF event is feasible and well tolerated. In-hospital initiation of sacubitril/valsartan is associated with early and sustained improvements in biomarkers of cardiac wall stress and myocardial injury, indicating pathophysiological benefits in a wide range of HFrEF patients.

Full Text:

PDF



DOI: https://doi.org/10.22146/aci.47680

Article Metrics

Abstract views : 1216 | views : 1736

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Budi Yuli Setianto

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.



ACI (Acta Cardiologia Indonesiana) is indexed by: 

   

  

ACI (Acta Cardiologia Indonesiana) is published by:

Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia

Address: Radiopoetro Building 2nd Floor, West Wing, Farmako Street, Sekip, Yogyakarta, Indonesia 55281

ACI (Acta Cardiologia Indonesiana) is endorsed by: